SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-0.51%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$168M
AUM Growth
+$168M
(-6.4%)
Cap. Flow
+$6.38M
Cap. Flow
% of AUM
3.81%
Top 10 Holdings %
Top 10 Hldgs %
57.53%
Holding
165
New
42
Increased
15
Reduced
19
Closed
25
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$17.5M |
| 2 |
MannKind Corp
MNKD
|
$15.6M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
$4.6M |
| 4 |
Arbutus Biopharma
ABUS
|
$4.14M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$3.26M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$25.5M |
| 2 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$10.1M |
| 3 |
Gilead Sciences
GILD
|
$5.78M |
| 4 |
AGEN
Agenus
AGEN
|
$4.89M |
| 5 |
Novavax
NVAX
|
$4.34M |
Sector Composition
| 1 | Healthcare | 85.48% |
| 2 | Communication Services | 2.75% |
| 3 | Materials | 0.4% |
| 4 | Energy | 0% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
MannKind Corp
MNKD
$1.41B
| $20.5M | 1.31% | 3,931,850 +2,997,829 | +321% | +$15.6M |
|
|
2
Teva Pharmaceuticals
TEVA
$21.1B
| $18.7M | 1.19% | 466,312 +437,709 | +1,530% | +$17.5M |
|
|
3
Acadia Pharmaceuticals
ACAD
$4.38B
| $13.9M | 0.89% | 557,013 +130,413 | +31% | +$3.26M |
|
4
Sarepta Therapeutics
SRPT
$1.78B
| $10.3M | 0.66% | 507,700 -14,341 | -3% | -$292K |
|
|
AEGR
5
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $8.28M | 0.53% | 116,626 -142,493 | -55% | -$10.1M |
|
|
6
Gilead Sciences
GILD
$140B
| $5.86M | 0.37% | 78,000 -76,871 | -50% | -$5.78M |
|
|
ANTH
7
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $5.27M | 0.34% | 1,714,958 -39,642 | -2% | -$122K |
|
|
MDVN
8
DELISTED
MEDIVATION, INC.
MDVN
| $4.79M | 0.31% | 75,016 -37,833 | -34% | -$2.41M |
|
|
TWTR
9
DELISTED
Twitter, Inc.
TWTR
| $4.6M | 0.29% | +72,300 | New | +$4.6M |
|
|
10
Arbutus Biopharma
ABUS
$711M
| $4.14M | 0.26% | +519,200 | New | +$4.14M |
|
11
Achieve Life Sciences
ACHV
$152M
| $2.94M | 0.19% | 352,800 -57,777 | -14% | -$482K |
|
|
CEMP
12
DELISTED
Cempra, Inc.
CEMP
| $2.94M | 0.19% | 237,000 +88,428 | +60% | +$1.1M |
|
13
Xoma
XOMA
$392M
| $2.78M | 0.18% | 413,390 -42,282 | -9% | -$285K |
|
14
Strata Skin Sciences
SSKN
$9.93M
| $2.75M | 0.18% | +4,290,716 | New | +$2.75M |
|
|
AVEO
15
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $2.74M | 0.17% | +1,490,121 | New | +$2.74M |
|
|
DMK
16
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $2.6M | 0.17% | +407,024 | New | +$2.6M |
|
|
KYTH
17
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $2.47M | 0.16% | +66,200 | New | +$2.47M |
|
18
Enanta Pharmaceuticals
ENTA
$180M
| $2.35M | 0.15% | +85,946 | New | +$2.35M |
|
|
EDAP
19
EDAP TMS
EDAP
$84.5M
| $2.29M | 0.15% | 770,618 -488,882 | -39% | -$1.45M |
|
20
Arcturus Therapeutics
ARCT
$462M
| $2.28M | 0.15% | +126,629 | New | +$2.28M |
|
21
CASI Pharmaceuticals
CASI
$35.8M
| $2.21M | 0.14% | 1,289,929 +110,973 | +9% | +$190K |
|
|
CPXX
22
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
| $2.18M | 0.14% | +679,592 | New | +$2.18M |
|
23
Rigel Pharmaceuticals
RIGL
$697M
| $2.17M | 0.14% | 762,900 +564,641 | +285% | +$1.61M |
|
|
BLUE
24
DELISTED
bluebird bio
BLUE
| $2.14M | 0.14% | +102,035 | New | +$2.14M |
|
25
Eli Lilly
LLY
$657B
| $2.08M | 0.13% | 40,700 +7,544 | +23% | +$385K |
|